Your session is about to expire
← Back to Search
Lidocaine for Postoperative Pain in Breast Cancer
Study Summary
This trial is testing whether or not lidocaine reduces persistent pain after breast cancer surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had breast surgery less than 6 months ago.I am 18 years old or older.I am having surgery using my own tissue for reconstruction.I have had chronic pain in the area of my upcoming surgery or nearby areas in the last 3 months.My surgery will not use general anesthesia but may use local or regional anesthesia.I am having a lumpectomy or mastectomy, for any reason including prevention.I have been diagnosed with cirrhosis of the liver.You are allergic to lidocaine.I have had heart rhythm problems without a pacemaker.
- Group 1: Intervention
- Group 2: Control
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are some popular indications for Lidocaine 20mg/ml?
"Lidocaine 20mg/ml is most commonly used as an intervention for increased intra ocular pressure (iop). However, it has a variety of other potential uses such as treating nasal irritation, increasing renal excretion of toxic substances, and reducing sciatica pain."
How many different medical clinics are conducting this study?
"The 12 hospitals participating in this clinical trial are the University of Alberta Hospital in Edmonton, Misericordia Community Hospital in Toronto, Humber River Hospital in Hamilton. The remaining 9 sites are located elsewhere."
How can I sign up to be a part of this experiment?
"1150 individuals, aged 18 to 100 years old and who experience pain post-operatively, are needed for this study. In order to be eligible, participants must also meet the following conditions: they must be undergoing a lumpectomy or mastectomy (which can include prophylactic surgery), and this procedure must be unilateral or bilateral."
Does this research require that participants be over the age of 18?
"This particular clinical trial is only looking for patients aged 18 to 100. In contrast, there are 211 other trials currently taking place that involve children and 3523 trials involving adults over the age of 65."
Is this research project looking for new participants right now?
"That is accurate. The clinical trial's listing on the website indicates that it is still recruiting patients. This specific study was posted on September 22nd, 2021 and last updated February 17th, 2022. They are aiming to enroll 1,150 participants at 12 different sites."
How many people are currently involved in this experiment?
"In order to move forward with this experiment, 1150 eligible individuals are needed. These potential participants must fit the bill of the inclusion criteria and can be recruited from different locations such as University of Alberta Hospital in Edmonton, Ontario and Misericordia Community Hospital in Toronto, Quebec."
Has the FDA cleared Lidocaine 20mg/ml for use?
"There is both efficacy and safety data from previous clinical trials, so our team has rated the Lidocaine 20mg/ml as being a 3 on a scale of 1 to 3."
Lidocaine 20mg/ml is a new medication, correct? Have there been other trials with this drug before?
"There are a total of 235 ongoing clinical trials researching the efficacy of Lidocaine 20mg/ml. Out of these, 60 are in Phase 3. Additionally, there are 1,475 different medical centres running these trials - with several being based in Duarte, California."
Share this study with friends
Copy Link
Messenger